Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2016 |
| Author/s |
author: Denise A Yardley Seock-Ah Im Joyce O'Shaughnessy Norikazu Masuda Igor N. Bondarenko |
| Publication date | November 4, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |